Clinical Study to Investigate Visual Performance of IOL: FineVision HP

Launched by BEAVER-VISITEC INTERNATIONAL, INC. · Jan 18, 2017

Keywords

ClinConnect Summary

Subjects participating in the trial will attend a total of 8 study visits (1 preoperative, 2 operative and 5 postoperative) over a period of 3 months, same as the surgeon's standard follow up protocol for bilateral cataract surgery with IOL implantation. Subjects would have the option for unscheduled visits if required medically.

Primary endpoint data will be collected at the final visit. Data analyses will be done in the end to support the study publication plan.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Cataracteous eyes with no comorbidity
• • Spontaneously emitting the desire for spectacle independence after surgery and with realistic expectation.
• • Availability, willingness and sufficient cognitive awareness to comply with examination procedures
• • Signed informed consent
• Exclusion Criteria:
• • Unrealistic expectation
• • Irregular astigmatism
• • Regular corneal astigmatism \>0.75 D on one or both eyes as measured by an automatic keratometer (regularity determined by the topography of the keratometry)
• • Difficulty for cooperation (distance from their home, general health condition)
• • Acute or chronic disease or illness that would increase risk or confound study results (e.g. diabetes mellitus (with retinopathy), immunocompromised, glaucoma etc...)
• • Any ocular comorbidity
• • History of ocular trauma or prior ocular surgery including refractive procedures
• • Capsule or zonular abnormalities that may affect postoperative centration or tilt of the lens (e.g. pseudoexfoliation syndrome, chronic Uveitis, Marfan's syndrome)
• • Pupil abnormalities (non-reactive, tonic pupils, abnormally shaped pupils or pupils that do not dilate under mesopic/scotopic conditions)
• • Complicated surgery